The menopause transition is often associated with genital changes, sexual discomfort and urinary issues—symptoms that collectively are known as the genitourinary syndrome of menopause (GSM). Hormone and nonhormone treatments are available to manage these symptoms.
Microablative Fractional Radiofrequency Treatment for Menopausal Women's Health
The article discusses the effects of microablative fractional radiofrequency treatment on postmenopausal women experiencing genitourinary syndrome of menopause (GSM). This treatment is relevant for managing symptoms such as sexual discomfort and urinary issues, which may impact women's health in Iran. Understanding these treatments could inform healthcare policies and women's health initiatives in the country.
👥 Key Players
📰 What Happened
The article discusses the effectiveness of microablative fractional radiofrequency treatment for managing genitourinary syndrome of menopause (GSM) symptoms in postmenopausal women. This treatment addresses issues like sexual discomfort and urinary problems.
- GSM affects many postmenopausal women, leading to significant health challenges.
- Microablative fractional radiofrequency is a non-invasive treatment option.
💡 Why It Matters
📚 Background
Menopause is a natural biological process that can lead to various health issues, particularly affecting women's sexual and urinary health. Understanding GSM is crucial for developing effective healthcare strategies.
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%